Bafna Pharmaceuticals standalone net profit rises 19.08% in the September 2025 quarter
(12 Nov 2025)

Back
Net profit of Bafna Pharmaceuticals rose 19.08% to Rs 3.12 crore in the quarter ended September 2025 as against Rs 2.62 crore during the previous quarter ended September 2024. Sales declined 12.03% to Rs 35.47 crore in the quarter ended September 2025 as against Rs 40.32 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales35.4740.32 -12
OPM %12.049.42 -
PBDT4.594.20 9
PBT3.122.62 19
NP3.122.62 19

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew